Dr Okuda shares his thoughts on the importance of patient dialogue in successful management of multiple sclerosis.
Darin Okuda, MD
Advertisement
Articles by Darin Okuda, MD
A multiple sclerosis expert, Dr Darin Okuda reviews long-term outcomes with ozanimod in DAYBREAK trial based on the number of relapses that was presented at EAN 2022.
Dr Darin Okuda discusses strategies for treatment selection and management of relapses in multiple sclerosis.
Advertisement
Latest Updated Articles
Managing Relapses in Patients With Multiple SclerosisPublished: August 4th 2022 | Updated:
- Long-Term Outcomes With Ozanimod Based on Number of MS Relapses
Published: August 4th 2022 | Updated:
- Advice for Clinical Management of Multiple Sclerosis
Published: August 4th 2022 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Understanding VTX3232’s Effects on Patients with Early-Stage Parkinson Disease
2
2025 CNS Annual Meeting: Top Expert Interviews and Key Takeaways
3
Ocrelizumab’s Encouraging Treatment Effects Across Conception Delivery and Breastfeeding
4
This Week on NeurologyLive® — October 27, 2025
5
